First Databank Announces Partnership with RxCap for Medication Adherence Mobile App
RxCap’s new consumer app will feature reminders, an adherence tracker and FDB Meducation® content, offering patients digital access to their...
Month: October 2020
Neuraptive Therapeutics Announces Activation of First Clinical Site in Phase 2 Study of NTX-001 for the Treatment of Nerve Repair and the Appointment of Industry Veteran David Pierce to Board of Directors
- Curtis National Hand Center first site activated to enroll patients in phase 2 study under the oversight of Dr. Kenneth...
ABBYY Accelerates U.S. Food and Drug Administration’s Public Health Initiatives
MILPITAS, Calif.--(BUSINESS WIRE)--#DigitalIntelligence--ABBYY announced today that the U.S. Food and Drug Administration (FDA) is using its Digital Intelligence platform to...
LabCorp Transforms the Clinical Trial Experience And Streamlines the Drug Development Process
Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and Experiences BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a...
Angle PLC Announces Submission Accepted by FDA for Substantive Review
Full Class II De Novo FDA Submission seeking clearance of the Parsortix system for metastatic breast cancer has successfully completed...
A Breakthrough Innovative Treatment for Allergic Rhinitis – Herbal Irrigation Nasal Therapy (HINT)
CHIAYI, TAIWAN / ACCESSWIRE / October 20, 2020 / Many studies in the past have reported that nasal irrigation is...
Neuromod Successfully Closes €10.5 Million Series B Financing for Tinnitus Treatment Device Lenire®
Plans to recruit 40 employees over the next 12 months in Europe, starting in Ireland and Germany Proceeds to accelerate...
Implanet and SeaSpine Announce FDA Clearance of the Mariner Cap System
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical...
Doctor Evidence, LLC (“DRE”) Expands Medical Strategy Advisory Board to Strengthen its Artificial Intelligence Solution in Drug Discovery
Medical Strategy Advisory Board (“MSAB”) to advise DRE on the convergence of expert AI-enabled technology in healthcare and the exponential...
DECN Announces Commencement of US-Based Donor Study for FDA EUA Guidance Testing for Their 10.5 Second Genviro! Saliva Swift COVID-19 Test Kits
Donor Study Activities Began, Friday October 16th at FDA and CLIA Certified Testing Lab; Data to Also Be Used for...
PainReform Highlights Surgical Advantages of PRF-110
Studies demonstrate unique benefits of PRF-100 beyond analgesic activity PRF-110 addresses potential concerns in the local administration of anesthetic related...
Enzolytics, Inc. Shares BioClonetics Immunotherapeutics, Inc. Company Update
Enzolytics provides guidance on engagement of manufacturer and OTC Markets Membership PLANO, TX / ACCESSWIRE / October 19, 2020 /...
StemoniX Announces Addition to Board of Directors
Company Announces Appointment of John Fletcher MAPLE GROVE, MN / ACCESSWIRE / October 19, 2020 / StemoniX, Inc. is pleased to...
Skin Science Soul by Dr. Sholar Continues to Transform Austin Non-Invasive Aesthetics by Launching the EMSUITE
AUSTIN, TX / ACCESSWIRE / October 19, 2020 / Skin Science Soul by Dr. Alina Sholar, who launched the BTL...
Sunshine Biopharma And University Of Georgia Team Up To Develop A New Anti-Coronavirus Drug
MONTREAL, QC / ACCESSWIRE / October 19, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
Arizona State University/Halberd Initiate Patent Application for Unique New Engineered Class of Covid-19 Antibody
JACKSON CENTER, PA / ACCESSWIRE / October 19, 2020 / Halberd Corporation (OTC PINK:HALB) today announced the creation of a...
Havn Life Sciences Announces Appointment of Dennis Staudt to the Board of Directors & Senior Management Reorganization
VANCOUVER, BC / ACCESSWIRE / October 19, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"),...
IntraBio Reports Further Detail on Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C
IB1001 demonstrated statistically significant and clinically meaningful change in both the primary and secondary endpoints Significant improvement in gait, fine...
Avinger Announces First US Cases with TIGEREYE(TM) Image-Guided CTO Crossing Catheter
REDWOOD CITY, CA / ACCESSWIRE / October 19, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first...
Planet 13 Expanding Las Vegas SuperStore
Planet 13 is expanding the largest dispensary in the world doubling the sales floor to service overwhelming customer demand and...